Evidence map›Paper›PMID 15484279›Full record

ArticleJournal of medical virology2004

Development and evaluation of a real-time nucleic acid sequence based amplification assay for rapid detection of influenza A.

Catherine Moore, Sam Hibbitts, Neil Owen, Sally A Corden, Graham Harrison, Julie Fox, Colin Gelder, Diana Westmoreland

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Development of a real-time nucleic acid sequence-based amplification assay for the rapid detection of Salmonella spp. from food.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Molecular beacons in diagnostics.F1000 medicine reports · 2012
    Article
  12. Article
  13. Article
  14. Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2010
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Detection of respiratory viruses by molecular methods.Clinical microbiology reviews · 2008
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Catherine MooreWales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff, United Kingdom. Catherine.moore@nphs.wales.nhs.uk
Sam Hibbitts
Neil Owen
Sally A Corden
Graham Harrison
Julie Fox
Colin Gelder
Diana Westmoreland
Cardiff University · GBCardiff Metropolitan University · GBGlangwili General Hospital · GBProvincial Laboratory of Public Health · CAUniversity Hospital Llandough · GBUniversity Hospital of Wales · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and introduction of effective treatment for influenza A in the form of neuraminidase inhibitors have made the rapid diagnosis of infection important especially in high-risk populations. The aim of this study was to develop a real-time nucleic acid sequenced based amplification (NASBA) using a molecular beacon that could detect a wide range of influenza A subtypes and strains in a single reaction by targeting a conserved region of the influenza genome, and to evaluate its sensitivity and specificity against traditional laboratory techniques on a range of clinical samples usefulness during the 2003/2004 influenza season. The results demonstrated the assay to be highly sensitive and specific, detecting <0.1 TCID50 of virus stock. Three hundred eighty-nine clinical samples were tested in total from two patient groups. Overall, the real-time NASBA assay detected 64% (66/103) more influenza positive samples than cell culture and direct immunofluorescence (IF) and, therefore, was shown to be more sensitive in detecting influenza A in a wide range of respiratory samples than traditional methods. In conclusion, the real-time influenza A assay demonstrated clinical usefulness in both hospital and community populations.

Indexed as

AgedCell Culture TechniquesDNA PrimersFemaleHumansInfluenza A virusInfluenza, HumanMaleReverse Transcriptase Polymerase Chain ReactionRNA, ViralSelf-Sustained Sequence ReplicationSensitivity and SpecificityDNA PrimersRNA, Viral

Identifiers

PMID15484279
PMCPMC7166529
OpenAlexW2084237311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.